BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15273504)

  • 1. Human disorders of ubiquitination and proteasomal degradation.
    Jiang YH; Beaudet AL
    Curr Opin Pediatr; 2004 Aug; 16(4):419-26. PubMed ID: 15273504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.
    Scheffner M; Nuber U; Huibregtse JM
    Nature; 1995 Jan; 373(6509):81-3. PubMed ID: 7800044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer.
    Eletr ZM; Huang DT; Duda DM; Schulman BA; Kuhlman B
    Nat Struct Mol Biol; 2005 Oct; 12(10):933-4. PubMed ID: 16142244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
    Tomaić V; Banks L
    Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymes of ubiquitination and deubiquitination.
    Neutzner M; Neutzner A
    Essays Biochem; 2012; 52():37-50. PubMed ID: 22708562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and interaction modes of 40 rice E2 ubiquitin-conjugating enzymes with 17 rice ARM-U-box E3 ubiquitin ligases.
    Bae H; Kim WT
    Biochem Biophys Res Commun; 2014 Feb; 444(4):575-80. PubMed ID: 24486490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation.
    Bays NW; Gardner RG; Seelig LP; Joazeiro CA; Hampton RY
    Nat Cell Biol; 2001 Jan; 3(1):24-9. PubMed ID: 11146622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-mediated proteolysis and human disease.
    Vu PK; Sakamoto KM
    Mol Genet Metab; 2000; 71(1-2):261-6. PubMed ID: 11001820
    [No Abstract]   [Full Text] [Related]  

  • 13. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications.
    Ciechanover A; Orian A; Schwartz AL
    J Cell Biochem Suppl; 2000; 34():40-51. PubMed ID: 10762014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3-ubiquitin ligases and recent progress in osteoimmunology.
    Asano Y; Matsumoto Y; Wada J; Rottapel R
    Front Immunol; 2023; 14():1120710. PubMed ID: 36911671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins.
    Mishra A; Godavarthi SK; Maheshwari M; Goswami A; Jana NR
    J Biol Chem; 2009 Apr; 284(16):10537-45. PubMed ID: 19233847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining protein stability and its relevance for plant growth and development.
    Schwechheimer C; Willige BC; Zourelidou M; Dohmann EM
    Methods Mol Biol; 2009; 479():147-71. PubMed ID: 19083189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs.
    Evans PC
    Expert Rev Mol Med; 2005 Jun; 7(12):1-19. PubMed ID: 15967057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angelman syndrome-associated point mutations in the Zn
    Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
    J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orchestra for assembly and fate of polyubiquitin chains.
    Kuhlbrodt K; Mouysset J; Hoppe T
    Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteasomal partner goes missing in Angelman syndrome.
    Huibregtse JM
    J Biol Chem; 2018 Nov; 293(47):18400-18401. PubMed ID: 30470726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.